Publication: Pancreatic steatosis: What should gastroenterologists know?
Issued Date
2015-01-01
Resource Type
ISSN
15908577
15908577
15908577
Other identifier(s)
2-s2.0-84929581319
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the Pancreas. Vol.16, No.3 (2015), 227-231
Suggested Citation
Varayu Prachayakul, Pitulak Aswakul Pancreatic steatosis: What should gastroenterologists know?. Journal of the Pancreas. Vol.16, No.3 (2015), 227-231. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/35598
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Pancreatic steatosis: What should gastroenterologists know?
Author(s)
Other Contributor(s)
Abstract
© 2015, E.S. Burioni Ricerche Bibliografiche. All rights reserved. When hyperechoic pancreatic parenchyma is observed on endoscopic or transabdominal ultrasound, fat infiltration of the pancreas is suspected. This condition was first reported by Ogilvie in 1993 and is termed fatty pancreas, pancreatic lipomatosis, non-alcoholic fatty pancreas, or pancreatic steatosis. Diagnosis of this condition mostly relies on imaging tools such as magnetic resonance imaging, computed tomography, or ultrasonography rather than histology. Although the condition is rare, it has clinical significance. There are multiple hypotheses regarded the etiology of this condition, listing factors such as viral infections, toxins, and congenital syndromes as possible causes. Metabolic syndrome and diabetes mellitus correlated with this condition. However, other etiologies should also be considered to aid specific treatment. In addition to a correlation between pancreatic steatosis and metabolic syndrome, relationships between pancreatic steatosis and worsened severity and prognosis of pancreatic cancer, increased complications after pancreatic surgery, and acute pancreatitis were reported. Gastroenterologists should be well informed about this condition for better care of these patients.